$SFES
SAFEGUARD SCIENTIFICS INC

2022 Q1 Form 10-Q Financial Statement

#000143774922011252 Filed on May 06, 2022

View on sec.gov

Income Statement

Concept 2022 Q1 2021 Q1 2021
Revenue $0.00 $0.00 $0.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $1.234M $1.700M $5.953M
YoY Change -27.41% -5.56% -17.32%
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses $1.234M $1.700M $5.953M
YoY Change -27.41% -5.56% -16.15%
Operating Profit -$1.234M -$2.463M -$2.463M
YoY Change -49.9% -30.27% -73.98%
Interest Expense -$3.478M $19.40M $12.12M
YoY Change -117.93% -818.52% -231.76%
% of Operating Profit
Other Income/Expense, Net -$1.997M $706.0K $706.0K
YoY Change -382.86% -119.79% -109.16%
Pretax Income -$6.709M $17.63M $17.63M
YoY Change -138.07% -210.1% -146.86%
Income Tax $0.00 $0.00 $0.00
% Of Pretax Income 0.0% 0.0%
Net Earnings -$6.709M $17.63M $17.63M
YoY Change -138.07% -210.1% -146.86%
Net Earnings / Revenue
Basic Earnings Per Share -$0.40 $0.84 $0.84
Diluted Earnings Per Share -$0.40 $0.84 $0.84
COMMON SHARES
Basic Shares Outstanding 16.59M 20.90M 20.90M
Diluted Shares Outstanding 16.59M 20.93M 20.93M

Balance Sheet

Concept 2022 Q1 2021 Q1 2021
SHORT-TERM ASSETS
Cash & Short-Term Investments $19.41M $21.80M $24.74M
YoY Change -10.98% 4.31% 58.58%
Cash & Equivalents $19.40M $21.80M $24.74M
Short-Term Investments $2.552M $4.549M
Other Short-Term Assets $3.491M $600.0K $5.539M
YoY Change 481.83% 0.0% 1007.8%
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets $22.90M $22.36M $30.28M
YoY Change 2.39% 3.57% 88.06%
LONG-TERM ASSETS
Property, Plant & Equipment $1.497M $1.736M $1.561M
YoY Change -13.77% -14.31% -13.28%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments $17.41M $27.81M $21.97M
YoY Change -37.4% -5.91% -56.4%
Other Assets $230.0K $292.0K $217.0K
YoY Change -21.23% -85.34% -72.88%
Total Long-Term Assets $23.30M $64.62M $23.75M
YoY Change -63.94% -8.75% -55.1%
TOTAL ASSETS
Total Short-Term Assets $22.90M $22.36M $30.28M
Total Long-Term Assets $23.30M $64.62M $23.75M
Total Assets $46.20M $86.98M $54.03M
YoY Change -46.89% -5.87% -21.7%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $0.00 $18.00K $41.00K
YoY Change -100.0% -87.23% -59.0%
Accrued Expenses $550.0K $577.0K $1.693M
YoY Change -4.68% 1.58% -50.21%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $1.010M $3.978M $1.734M
YoY Change -74.61% 24.9% -50.46%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities $50.00K $50.00K $1.728M
YoY Change 0.0% -95.5% -36.0%
Total Long-Term Liabilities $50.00K $50.00K $1.728M
YoY Change 0.0% -95.5% -36.0%
TOTAL LIABILITIES
Total Short-Term Liabilities $1.010M $3.978M $1.734M
Total Long-Term Liabilities $50.00K $50.00K $1.728M
Total Liabilities $2.649M $5.992M $3.462M
YoY Change -55.79% -9.21% -44.16%
SHAREHOLDERS EQUITY
Retained Earnings -$716.3M -$719.0M
YoY Change -0.37% 0.81%
Common Stock $807.9M $809.3M
YoY Change -0.16% -0.46%
Preferred Stock
YoY Change
Treasury Stock (at cost) $48.03M $9.237M
YoY Change 419.93% -33.64%
Treasury Stock Shares $5.094M $630.0K
Shareholders Equity $43.55M $81.00M $50.57M
YoY Change
Total Liabilities & Shareholders Equity $46.20M $86.98M $54.03M
YoY Change -46.89% -5.87% -21.7%

Cashflow Statement

Concept 2022 Q1 2021 Q1 2021
OPERATING ACTIVITIES
Net Income -$6.709M $17.63M $17.63M
YoY Change -138.07% -210.1% -146.86%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities -$1.001M -$2.157M -$8.152M
YoY Change -53.59% -15.44% 0.11%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities -$3.102M $8.400M $58.11M
YoY Change -136.93% -660.0% -4570.31%
Cash From Investing Activities -$3.102M $8.419M $58.11M
YoY Change -136.85% -649.18% -4679.51%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $779.0K $0.00 $40.66M
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -$1.229M -$88.00K -$40.80M
YoY Change 1296.59% 700.0% 101897.5%
NET CHANGE
Cash From Operating Activities -$1.001M -$2.157M -$8.152M
Cash From Investing Activities -$3.102M $8.419M $58.11M
Cash From Financing Activities -$1.229M -$88.00K -$40.80M
Net Change In Cash -$5.332M $6.174M $9.163M
YoY Change -186.36% -250.77% -196.94%
FREE CASH FLOW
Cash From Operating Activities -$1.001M -$2.157M -$8.152M
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2022Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
16410543
CY2022Q1 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2021Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2022Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.10
CY2021Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.10
CY2022Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
1000000
CY2021Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
1000000
CY2022Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.10
CY2021Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.10
CY2022Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
83333000
CY2021Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
83333000
CY2022Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
21573000
CY2022Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
21573000
CY2021Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
21573000
CY2021Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
21573000
CY2021Q4 us-gaap Common Stock Value
CommonStockValue
2157000 USD
CY2022Q1 us-gaap Treasury Stock Shares
TreasuryStockShares
5094000
CY2021Q4 us-gaap Treasury Stock Shares
TreasuryStockShares
5068000
CY2022Q1 us-gaap Number Of Operating Segments
NumberOfOperatingSegments
1 pure
CY2021Q1 sfe Long Term Incentive Plan Payments
LongTermIncentivePlanPayments
0 USD
CY2022Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
19407000 USD
CY2021Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
24739000 USD
CY2022Q1 us-gaap Restricted Cash Current
RestrictedCashCurrent
25000 USD
CY2021Q4 us-gaap Restricted Cash Current
RestrictedCashCurrent
25000 USD
CY2022Q1 us-gaap Trading Securities
TradingSecurities
2552000 USD
CY2021Q4 us-gaap Trading Securities
TradingSecurities
4549000 USD
CY2022Q1 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
914000 USD
CY2021Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
965000 USD
CY2022Q1 us-gaap Assets Current
AssetsCurrent
22898000 USD
CY2021Q4 us-gaap Assets Current
AssetsCurrent
30278000 USD
CY2022Q1 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
1497000 USD
CY2021Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
1561000 USD
CY2022Q1 us-gaap Investments In Affiliates Subsidiaries Associates And Joint Ventures
InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures
21573000 USD
CY2021Q4 us-gaap Investments In Affiliates Subsidiaries Associates And Joint Ventures
InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures
21972000 USD
CY2022Q1 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
230000 USD
CY2021Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
217000 USD
CY2022Q1 us-gaap Assets
Assets
46198000 USD
CY2021Q4 us-gaap Assets
Assets
54028000 USD
CY2022Q1 us-gaap Accounts Payable Current
AccountsPayableCurrent
0 USD
CY2021Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
41000 USD
CY2022Q1 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
85000 USD
CY2021Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
794000 USD
CY2022Q1 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
550000 USD
CY2021Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
524000 USD
CY2022Q1 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
375000 USD
CY2021Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
375000 USD
CY2022Q1 us-gaap Liabilities Current
LiabilitiesCurrent
1010000 USD
CY2021Q4 us-gaap Liabilities Current
LiabilitiesCurrent
1734000 USD
CY2022Q1 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
1589000 USD
CY2021Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
1678000 USD
CY2022Q1 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
50000 USD
CY2021Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
50000 USD
CY2022Q1 us-gaap Liabilities
Liabilities
2649000 USD
CY2021Q4 us-gaap Liabilities
Liabilities
3462000 USD
CY2022Q1 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2021Q4 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2022Q1 us-gaap Common Stock Value
CommonStockValue
2157000 USD
CY2022Q1 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
805787000 USD
CY2021Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
806638000 USD
CY2022Q1 us-gaap Treasury Stock Value
TreasuryStockValue
48026000 USD
CY2021Q4 us-gaap Treasury Stock Value
TreasuryStockValue
48569000 USD
CY2022Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-716344000 USD
CY2021Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-709635000 USD
CY2022Q1 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-25000 USD
CY2021Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-25000 USD
CY2022Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
43549000 USD
CY2021Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
50566000 USD
CY2022Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
46198000 USD
CY2021Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
54028000 USD
CY2022Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1234000 USD
CY2021 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
2463000 USD
CY2022Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-1234000 USD
CY2021 us-gaap Operating Income Loss
OperatingIncomeLoss
-2463000 USD
CY2022Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-1997000 USD
CY2021 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
706000 USD
CY2022Q1 us-gaap Investment Income Interest
InvestmentIncomeInterest
101000 USD
CY2021 us-gaap Investment Income Interest
InvestmentIncomeInterest
53000 USD
CY2022Q1 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-3579000 USD
CY2021 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
19329000 USD
CY2022Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-6709000 USD
CY2021 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
17625000 USD
CY2022Q1 us-gaap Profit Loss
ProfitLoss
-6709000 USD
CY2021 us-gaap Profit Loss
ProfitLoss
17625000 USD
CY2022Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.40
CY2021 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.84
CY2022Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.40
CY2021 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.84
CY2022Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
16587000
CY2021 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
20902000
CY2022Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
16587000
CY2021 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
20930000
CY2022Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-1001000 USD
CY2021Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-2157000 USD
CY2022Q1 us-gaap Proceeds From Divestiture Of Businesses And Interests In Affiliates
ProceedsFromDivestitureOfBusinessesAndInterestsInAffiliates
298000 USD
CY2021Q1 us-gaap Proceeds From Divestiture Of Businesses And Interests In Affiliates
ProceedsFromDivestitureOfBusinessesAndInterestsInAffiliates
9419000 USD
CY2022Q1 us-gaap Payments For Advance To Affiliate
PaymentsForAdvanceToAffiliate
3400000 USD
CY2021Q1 us-gaap Payments For Advance To Affiliate
PaymentsForAdvanceToAffiliate
1000000 USD
CY2022Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-3102000 USD
CY2021Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
8419000 USD
CY2022Q1 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
779000 USD
CY2021Q1 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
-0 USD
CY2022Q1 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
450000 USD
CY2021Q1 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
88000 USD
CY2022Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-1229000 USD
CY2021Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-88000 USD
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-5332000 USD
CY2021Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
6174000 USD
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
24764000 USD
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
15601000 USD
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
19432000 USD
CY2021Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
21775000 USD
CY2021Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
50566000 USD
CY2022Q1 us-gaap Profit Loss
ProfitLoss
-6709000 USD
CY2022Q1 us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
779000 USD
CY2022Q1 sfe Stock Issued During Period Value Restricted Stock Award Withheld For Taxes
StockIssuedDuringPeriodValueRestrictedStockAwardWithheldForTaxes
-303000 USD
CY2022Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
168000 USD
CY2022Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
43549000 USD
CY2020Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
62875000 USD
CY2021Q1 us-gaap Profit Loss
ProfitLoss
17625000 USD
CY2021Q1 sfe Stock Issued During Period Value Restricted Stock Award Withheld For Taxes
StockIssuedDuringPeriodValueRestrictedStockAwardWithheldForTaxes
-370000 USD
CY2021Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
122000 USD
CY2021Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
80992000 USD
CY2022Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
19400000 USD
CY2022Q1 us-gaap Equity Method Investments
EquityMethodInvestments
17409000 USD
CY2021Q4 us-gaap Equity Method Investments
EquityMethodInvestments
21208000 USD
CY2022Q1 us-gaap Equity Securities Without Readily Determinable Fair Value Amount
EquitySecuritiesWithoutReadilyDeterminableFairValueAmount
3316000 USD
CY2021Q4 us-gaap Equity Securities Without Readily Determinable Fair Value Amount
EquitySecuritiesWithoutReadilyDeterminableFairValueAmount
5313000 USD
CY2022Q1 us-gaap Advances To Affiliate
AdvancesToAffiliate
3400000 USD
CY2021Q4 us-gaap Advances To Affiliate
AdvancesToAffiliate
0 USD
CY2022Q1 sfe Investments And Advances To Affiliates Current And Noncurrent
InvestmentsAndAdvancesToAffiliatesCurrentAndNoncurrent
24125000 USD
CY2021Q4 sfe Investments And Advances To Affiliates Current And Noncurrent
InvestmentsAndAdvancesToAffiliatesCurrentAndNoncurrent
26521000 USD
CY2022Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
314000 USD
CY2021Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
245000 USD
CY2022Q1 us-gaap Profit Loss
ProfitLoss
-6709000 USD
CY2021Q1 us-gaap Profit Loss
ProfitLoss
17625000 USD
CY2022Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
16587000
CY2021Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
20902000
CY2022Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.40
CY2021Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.84
CY2022Q1 us-gaap Profit Loss
ProfitLoss
-6709000 USD
CY2021Q1 us-gaap Profit Loss
ProfitLoss
17625000 USD
CY2022Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
16587000
CY2021Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
20902000
CY2022Q1 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
0
CY2021Q1 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
28000
CY2022Q1 us-gaap Incremental Common Shares Attributable To Written Put Options
IncrementalCommonSharesAttributableToWrittenPutOptions
0
CY2021Q1 us-gaap Incremental Common Shares Attributable To Written Put Options
IncrementalCommonSharesAttributableToWrittenPutOptions
0
CY2022Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
16587000
CY2021Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
20930000
CY2022Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.40
CY2021Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.84
CY2022Q1 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
452000 USD
CY2022Q1 sfe Lessee Subleaseexpected Receipts Remainder Of Fiscal Year
LesseeSubleaseexpectedReceiptsRemainderOfFiscalYear
408000 USD
CY2022Q1 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
607000 USD
CY2022Q1 sfe Lessee Sublease Expected Receipts Year One
LesseeSubleaseExpectedReceiptsYearOne
557000 USD
CY2022Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
613000 USD
CY2022Q1 sfe Lessee Subleaseexpected Receipts Year Two
LesseeSubleaseexpectedReceiptsYearTwo
573000 USD
CY2022Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
619000 USD
CY2022Q1 sfe Lessee Subleaseexpected Receipts Year Three
LesseeSubleaseexpectedReceiptsYearThree
590000 USD
CY2022Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
207000 USD
CY2022Q1 sfe Lessee Subleaseexpected Receipts Year Four
LesseeSubleaseexpectedReceiptsYearFour
199000 USD
CY2022Q1 us-gaap Lessor Operating Lease Payments To Be Received Five Years
LessorOperatingLeasePaymentsToBeReceivedFiveYears
0 USD
CY2022Q1 sfe Lessee Subleaseexpected Receipts Year Five
LesseeSubleaseexpectedReceiptsYearFive
0 USD
CY2022Q1 us-gaap Lessee Operating Lease Liability Payments Due After Year Five
LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive
0 USD
CY2022Q1 sfe Lessee Subleaseexpected Receipts Thereafter
LesseeSubleaseexpectedReceiptsThereafter
0 USD
CY2022Q1 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
2498000 USD
CY2022Q1 sfe Lessee Sublease Expected Receipts Total
LesseeSubleaseExpectedReceiptsTotal
2327000 USD
CY2022Q1 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
534000 USD
CY2022Q1 us-gaap Operating Lease Liability
OperatingLeaseLiability
1964000 USD
CY2022Q1 us-gaap Deferred Compensation Liability Current And Noncurrent
DeferredCompensationLiabilityCurrentAndNoncurrent
0 USD
CY2022Q1 sfe Employee And Severance Agreement Maximum Aggregate Exposure
EmployeeAndSeveranceAgreementMaximumAggregateExposure
900000 USD

Files In Submission

Name View Source Status
0001437749-22-011252-index-headers.html Edgar Link pending
0001437749-22-011252-index.html Edgar Link pending
0001437749-22-011252.txt Edgar Link pending
0001437749-22-011252-xbrl.zip Edgar Link pending
ex_342388.htm Edgar Link pending
ex_342389.htm Edgar Link pending
ex_342390.htm Edgar Link pending
ex_342391.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
sfe-20220331.xsd Edgar Link pending
sfe-20220331_cal.xml Edgar Link unprocessable
sfe-20220331_def.xml Edgar Link unprocessable
sfe-20220331_lab.xml Edgar Link unprocessable
sfe-20220331_pre.xml Edgar Link unprocessable
sfe20220331_10q.htm Edgar Link pending
sfe20220331_10q_htm.xml Edgar Link completed
Show.js Edgar Link pending